BRD4-IN-7

• UNSPSC Description:

  BRD4-IN-7 (compound 120) is a BRD4 inhibitor(extracted from patent CN107721975A).

• Target Antigen:

  Epigenetic Reader Domain

• Type:

  Reference compound

• Related Pathways:

  Epigenetics

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/brd4-in-7.html

• Solubility:

  10 mM in DMSO

• Smiles:

  CN1C=C(C2=C(OC3=C(F)C=C(F)C=C3)C=CC(C(NC4=CC=C(N(C)C)C=C4)=O)=C2)C5=C(NC=C5)C1=O

• Molecular Weight:

  514.52

• References & Citations:

  [1]WANG, Le, et al. Pyrrolopyridinone derivatives as bromodomain inhibitors and their preparation. WO2013097601.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  1446232-98-9